Howard B - Search Results

1

Analysis of human serum proteins by liquid phase isoelectric focusing and matrix-assisted laser desorption/ionization-mass spectrometry.

Wang MZ, Howard B, Campa MJ, Patz EF Jr, Fitzgerald MC. Wang MZ, et al. Among authors: howard b. Proteomics. 2003 Sep;3(9):1661-6. doi: 10.1002/pmic.200300513. Proteomics. 2003. PMID: 12973721

2

Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis.

Howard BA, Wang MZ, Campa MJ, Corro C, Fitzgerald MC, Patz EF Jr. Howard BA, et al. Proteomics. 2003 Sep;3(9):1720-4. doi: 10.1002/pmic.200300514. Proteomics. 2003. PMID: 12973732

3

Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer.

Campa MJ, Wang MZ, Howard B, Fitzgerald MC, Patz EF Jr. Campa MJ, et al. Among authors: howard b. Cancer Res. 2003 Apr 1;63(7):1652-6. Cancer Res. 2003. PMID: 12670919

4

Thermodynamic analysis of cyclosporin a binding to cyclophilin a in a lung tumor tissue lysate.

Wang MZ, Shetty JT, Howard BA, Campa MJ, Patz EF Jr, Fitzgerald MC. Wang MZ, et al. Anal Chem. 2004 Aug 1;76(15):4343-8. doi: 10.1021/ac049536j. Anal Chem. 2004. PMID: 15283571

5

Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer.

Howard BA, Zheng Z, Campa MJ, Wang MZ, Sharma A, Haura E, Herndon JE 2nd, Fitzgerald MC, Bepler G, Patz EF Jr. Howard BA, et al. Lung Cancer. 2004 Dec;46(3):313-23. doi: 10.1016/j.lungcan.2004.05.013. Lung Cancer. 2004. PMID: 15541816

6

Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo.

Howard BA, Furumai R, Campa MJ, Rabbani ZN, Vujaskovic Z, Wang XF, Patz EF Jr. Howard BA, et al. Cancer Res. 2005 Oct 1;65(19):8853-60. doi: 10.1158/0008-5472.CAN-05-1219. Cancer Res. 2005. PMID: 16204056

7

FDG Uptake on Positron Emission Tomography Correlates with Survival and Time to Recurrence in Patients with Stage I Non-Small-Cell Lung Cancer.

Kwon W, Howard BA, Herndon JE, Patz EF Jr. Kwon W, et al. J Thorac Oncol. 2015 Jun;10(6):897-902. doi: 10.1097/JTO.0000000000000534. J Thorac Oncol. 2015. PMID: 25811445 Free article.

8

Reply to "Prognostic Value of Fluorodeoxyglucose-Positron Emission Tomography".

Kwon W, Howard BA, Herndon JE, Patz EF Jr. Kwon W, et al. J Thorac Oncol. 2015 Oct;10(10):e102. doi: 10.1097/JTO.0000000000000637. J Thorac Oncol. 2015. PMID: 26398827 Free article. No abstract available.

9

PET-CT: current applications and new developments in the thorax.

Erasmus JJ, Mawlawi O, Howard B, Patz EF Jr. Erasmus JJ, et al. Among authors: howard b. Semin Respir Crit Care Med. 2014 Feb;35(1):145-56. doi: 10.1055/s-0033-1363459. Epub 2014 Jan 30. Semin Respir Crit Care Med. 2014. PMID: 24481767 Review.

10

Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT.

Howard BA, Morgan R, Thorpe MP, Turkington TG, Oldan J, James OG, Borges-Neto S. Howard BA, et al. Ann Nucl Med. 2017 Oct;31(8):623-628. doi: 10.1007/s12149-017-1192-1. Epub 2017 Jul 8. Ann Nucl Med. 2017. PMID: 28689358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,833 results

Search Page